M
Michael J. Mack
Researcher at Scott & White Hospital
Publications - 634
Citations - 36680
Michael J. Mack is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 89, co-authored 519 publications receiving 28877 citations. Previous affiliations of Michael J. Mack include Baylor University Medical Center & Medical City Dallas Hospital.
Papers
More filters
Journal ArticleDOI
ECMO: We Need to Vent About the Need to Vent!
Journal ArticleDOI
Impact of Predilation During Transcatheter Aortic Valve Replacement: Insights From the PARTNER 3 Trial
Julien Ternacle,Karim Al-Azizi,Molly Szerlip,Srinivasa Potluri,Mohanad Hamandi,Philipp Blanke,Jonathon Leipsic,Abdellaziz Dahou,Erwan Salaun,Flavien Vincent,Erin Rogers,Maria Alu,Michael T. Lu,Xiao Yu,Vinod H. Thourani,Rebecca T. Hahn,Martin B. Leon,Philippe Pibarot,Michael J. Mack +18 more
TL;DR: Predilation and direct TAVR are safe in patients with low surgical risk and favorable aortic valve anatomy and did not predispose to more postdilation.
Journal ArticleDOI
Association between serum albumin and outcomes in heart failure and secondary mitral regurgitation: the COAPT trial
Kent Feng,Andrew P. Ambrosy,Ditian Li,Jeremy Kong,Jonathan G. Zaroff,Jacob M. Mishell,Ivy A. Ku,Andrea Scotti,Augustin Coisne,Björn Redfors,Michael J. Mack,William T. Abraham,JoAnn Lindenfeld,Gregg W. Stone +13 more
TL;DR: In this article , the relationship between albumin levels and outcomes in patients with heart failure and secondary mitral regurgitation (SMR) has not been described, but low serum albumin level is associated with poor prognosis in numerous chronic disease states.
Journal ArticleDOI
Response by Pibarot et al to Letter Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
TL;DR: The results of the PARTNER 3 trial suggest that TAVR is associated with greater reduction in Zva and thus in LV energy cost compared with SAVR, and Zva has the advantage of providing a more comprehensive assessment of the effect of aortic valve replacement (AVR) on the overall performance of the ventriculo-valvulo-arterial system.
Journal ArticleDOI
Predicting risk in procedures for aortic stenosis: the next step forward.
TL;DR: Risk adjustment allows for a more meaningful analysis of hospitals or therapies for comparative safety and/or effectiveness of treatment and helps to obtain valid information and not misinformation from the ‘correction’.